Renewable Energy Group Limited REG's independent Directors have presented a recommendation to shareholders
December 2015 — The independent Directors of Renewable Energy Group Limited (REG) have prepared an assessment of the offer made by BlackRock and their recommendation to the company's shareholders.
REG was an AIM-listed, UK-focused multi-divisional renewables company operating 111MW of power in the UK, including 11 wind projects in Cambridgeshire, Cornwall, County Durham, Yorkshire, Lancashire, Cumbria and Gwynedd.
BlackRock is one of the world's preeminent asset management firms
Our role in the transaction
Oaklins Smith & Williamson, based in the UK, acted as financial advisor to the independent Directors in relation to their assessment of the offer and recommendation to shareholders.
Talk to the deal team
Related deals
Nexxtlab has successfully raised funding to support its growth
Nexxtlab, a Luxembourg-based energy technology company, has raised growth capital from an experienced international energy player. The investment marks an important milestone in Nexxtlab’s development and will support the company’s commercial expansion across Europe, continued product innovation and the further scaling of its energy management platform.
Learn moreLemvig Biogasanlæg has been acquired by BioticNRG
BioticNRG has acquired Lemvig Biogasanlæg A.M.B.A. in a transaction that expands its presence in the biogas sector and establishes a strategic platform for further growth in the Danish renewable energy market. The acquisition supports the continued development of Lemvig Biogasanlæg while strengthening the production of green gas in Denmark.
Learn moreEmpresa Eléctrica Cochrane has completed a corporate restructuring and liability management process
AES Andes S.A. has completed a corporate restructuring and liability management process that included the acquisition of Toesca’s indirect interest in Empresa Eléctrica Cochrane S.p.A. (Cochrane); the prepayment of Cochrane AES’s 5.50% 2027 international bond; the exchange of Cochrane’s BCOCH-A local bonds for new international bonds issued in Rule 144A/Regulation S format for US$485 million; and the merger between Cochrane and AES Andes.
Learn more